A Study of Baricitinib in Participants With Systemic Lupus Erythematosus (SLE)
Clinical trial NCT03843125 · TERMINATED
Trial details
- NCT number
- NCT03843125
- Sponsor
- Eli Lilly and Company
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-09-09
- Primary completion
- 2022-04-01
- Enrollment
- 1147
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.